Wainwright sustains Buy on VERU shares on financial outcomes

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ:VERU), with a price target maintained at $3.00. Currently trading at …

$3.00
OFF

Wainwright Sustains Buy On VERU Shares On Financial Outcomes

2 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ:VERU), with a price target maintained at $3.00. Currently trading at …

investing.com

$5.00
OFF

Veru's (VERU) Buy Rating Reaffirmed At HC Wainwright - MarketBeat

2 weeks from now

Jan 2, 2025 · Separately, Oppenheimer reiterated an "outperform" rating and set a $5.00 price target on shares of Veru in a research report on Tuesday, November 5th. Get Our Latest …

marketbeat.com

$3.00
OFF

H.C. Wainwright Maintains Target On Veru Stock Post-sale

2 weeks from now

Jan 2, 2025 · On Thursday, H.C. Wainwright reaffirmed their optimistic stance on Veru Inc. (NASDAQ:VERU), maintaining a Buy rating and a price target of $3.00. Currently trading at …

investing.com

$0.65
OFF

Veru’s (VERU) “Buy” Rating Reaffirmed At HC Wainwright

2 weeks from now

Dec 22, 2024 · NASDAQ VERU opened at $0.65 on Friday. The firm has a market cap of $95.15 million, a price-to-earnings ratio of -1.35 and a beta of -0.50. Veru has a 12-month low of $0.36 …

etfdailynews.com

$3.00
OFF

Wainwright Sustains Buy On VERU Shares On Financial Outcomes

2 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ: VERU), with a price target maintained at $3.00.Currently trading at …

investing.com

$0.65
OFF

HC Wainwright Reaffirms Buy Rating For Veru (NASDAQ:VERU)

2 weeks from now

Dec 22, 2024 · Shares of VERU stock opened at $0.65 on Friday. Veru has a 52 week low of $0.36 and a 52 week high of $1.92. The firm’s 50-day simple moving average is $0.74 and its …

defenseworld.net

$0.06
OFF

Veru (NASDAQ:VERU) Receives "Buy" Rating From HC Wainwright

2 weeks from now

Dec 20, 2024 · The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Veru had a negative return on equity of …

marketbeat.com

$3.00
OFF

Strong Buy Rating For Veru Inc. On Solid Revenue Growth And …

2 weeks from now

Aug 9, 2024 · Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Veru (VERU – Research Report), retaining the price target of $3.00.. Yi Chen has given his Buy rating due to …

businessinsider.com

$2.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Veru (VERU)

2 weeks from now

Aug 14, 2023 · In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Veru (VERU – Research Report), with a price target of $2.00. The company’s shares …

businessinsider.com

$3
OFF

HC Wainwright & Co. Reiterates Buy On Veru, Maintains $3 Price …

2 weeks from now

Dec 20, 2024 · HC Wainwright Co. analyst Yi ... VERU) with a Buy and maintains $3 price target. HC Wainwright Co. analyst Yi Chen reiterates Veru (NASDAQ:VERU) with a Buy and... Invest …

sahmcapital.com

$3
OFF

HC Wainwright & Co. Reiterates Buy On Veru, Maintains $3 Price …

2 weeks from now

HC Wainwright & Co. analyst Yi Chen reiterates Veru (NASDAQ:VERU) with a Buy and maintains $3 price target. Webull Corporation. Webull Financial LLC (US) ... Market data, development, …

webull.ca

$3.00
OFF

H.C. Wainwright Reiterates Buy Rating On Veru, Inc. (VERU)

2 weeks from now

Dec 20, 2024 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $3.00 price target on Veru, Inc. (NASDAQ: VERU).The analyst commented: "Earlier this week, Veru reported its …

streetinsider.com

$2.00
OFF

H.C. Wainwright Sticks To Its Buy Rating For Veru (VERU)

2 weeks from now

May 15, 2023 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU – Research Report) today and set a price target of $2.00. The compan...

businessinsider.com

$18.00
OFF

Veru (VERU) Gets A Buy From H.C. Wainwright | Markets Insider

2 weeks from now

Dec 7, 2022 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU - Research Report) today and set a price target of $18.00. The companys shar...

businessinsider.com

FAQs about Wainwright sustains Buy on VERU shares on financial outcomes Coupon?

Should you buy Veru (Veru – get free report)?

Veru (NASDAQ:VERU – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report issued on Friday,Benzinga reports. They presently have a $3.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 361.54% from the company’s previous close. ...

Should you buy Veru (Veru) stock?

Chen covers the Healthcare sector, focusing on stocks such as EyePoint Pharmaceuticals, OpGen, and First Wave Bio. According to TipRanks, Chen has an average return of -30.5% and a 24.74% success rate on recommended stocks. Currently, the analyst consensus on Veru is a Moderate Buy with an average price target of $1.50. ...

Who owns Veru Inc?

Institutional investors own 47.16% of the company’s stock. (Get Free Report) Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). ...

Why has Yi Chen rated Veru Inc (Vu) a buy?

Yi Chen has given his Buy rating due to a combination of factors, including the company’s recent financial performance and the potential of its pharmaceutical developments. Veru Inc. reported a higher-than-expected net revenue of $4 million, which is an 18% year-over-year growth, surpassing the projected $3 million. ...

Is Veru a biopharmaceutical company?

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. ...